Distinguishing true recurrence from second primary breast cancer using molecular clonality analysis in clinical practice.

Snellen TIM, Lips EH, Bosch LJW, Wiersma T, Scholten AN, Noë M, Vrancken Peeters MTFD, Dezentjé VO

Open source

DOI
10.1016/j.ctarc.2026.101436
Published
2026 Sep 10
Container
Cancer treatment and research communications
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ctarc.2026.101436,
  title = {Distinguishing true recurrence from second primary breast cancer using molecular clonality analysis in clinical practice.},
  author = {Snellen TIM and Lips EH and Bosch LJW and Wiersma T and Scholten AN and Noë M and Vrancken Peeters MTFD and Dezentjé VO},
  year = {2026},
  journal = {Cancer treatment and research communications},
  doi = {10.1016/j.ctarc.2026.101436},
  url = {https://doi.org/10.1016/j.ctarc.2026.101436}
}

RIS

TY  - JOUR
TI  - Distinguishing true recurrence from second primary breast cancer using molecular clonality analysis in clinical practice.
AU  - Snellen TIM
AU  - Lips EH
AU  - Bosch LJW
AU  - Wiersma T
AU  - Scholten AN
AU  - Noë M
AU  - Vrancken Peeters MTFD
AU  - Dezentjé VO
PY  - 2026
JO  - Cancer treatment and research communications
DO  - 10.1016/j.ctarc.2026.101436
UR  - https://doi.org/10.1016/j.ctarc.2026.101436
ER  - 

APA

TIM, S., EH, L., LJW, B., T, W., AN, S., M, N., MTFD, V. P., & VO, D. (2026). Distinguishing true recurrence from second primary breast cancer using molecular clonality analysis in clinical practice.. Cancer treatment and research communications. https://doi.org/10.1016/j.ctarc.2026.101436

Source records